Australia's most trusted
source of pharma news
Friday, 12 December 2025
Posted 11 December 2025 AM
A new pharma sentiment index has exposed a "deeply pessimistic mood" across industry as it tries to forge a path forward through one of the most difficult times in decades.
The headline score for the inaugural Biopharma Sentiment Index (BPSI) sits at 78, well below the 'neutral' baseline of 100. The results for Q4 2025, were drawn from a survey conducted in October of almost 1500 Endpoints News readers, a quarter of whom were C-suiters.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.